Cambium Bio (ASX:CMB) FCF Yield % : -10.98 (As of May. 23, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Cambium Bio FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Cambium Bio's Trailing 12-Month Free Cash Flow is A$-0.47 Mil, and Market Cap is A$4.29 Mil. Therefore, Cambium Bio's FCF Yield % for today is -10.98%.

The historical rank and industry rank for Cambium Bio's FCF Yield % or its related term are showing as below:

ASX:CMB' s FCF Yield % Range Over the Past 10 Years
Min: -41.82 Med: -7.81 Max: 264.77
Current: -10.98

During the past 10 years, the highest FCF Yield % of Cambium Bio was 264.77%. The lowest was -41.82%. And the median was -7.81%.

ASX:CMB's FCF Yield % is ranked better than
56.31% of 1554 companies
in the Biotechnology industry
Industry Median: -14.335 vs ASX:CMB: -10.98

Cambium Bio's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Cambium Bio FCF Yield % Historical Data

The historical data trend for Cambium Bio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambium Bio FCF Yield % Chart

Cambium Bio Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

-21.15

-9.86

10.73

-19.25

-30.77

Cambium Bio Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-17.37	-15.73	-0.58	-57.53	31.76

Competitive Comparison of Cambium Bio's FCF Yield %

For the Biotechnology subindustry, Cambium Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cambium Bio's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cambium Bio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Cambium Bio's FCF Yield % falls into.

Cambium Bio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Cambium Bio's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.66	/	2.145059
	=	-30.77%

Cambium Bio's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0.146	*	2	/	0.919311
	=	31.76%

Cambium Bio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Cambium Bio FCF Yield % Related Terms

Thank you for viewing the detailed overview of Cambium Bio's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cambium Bio (ASX:CMB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cambium Bio Ltd (ASX:CMB) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Goodhope Street, Paddington, Sydney, NSW, AUS, 2021

Website

https://www.regeneus.com.au

Regeneus Ltd is a clinical-stage regenerative medicine company in Australia. It mainly develops a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases. The company uses stem cell and immuno-oncology technologies to develop cell-based therapies. Its product pipeline consists of two platform technologies, Progenza and Sygenus, across three target therapeutic areas namely osteoarthritis, neuropathic pain, and skin wound healing. The company has one operating segment being the development of innovative cell-based therapies to address significant unmet medical needs in human and veterinary health.

Cambium Bio (ASX:CMB) Headlines

No Headlines